PolymarketVerifica disponibilitàSenza KYC2% di commissioneDati di risoluzione verificatiDiscretamente calibratoProbabilità implicita attualeDecember 65%+2.0pt
Qualita del mercato
31 / 100
Bassa qualitàVolume 24h
0 €
Liquidità
589,8 €
Bassa liquiditàBid / Ask
21.0% / 29.0%
Spread
8.0 pt
Spread ampioVariazione 7g
-2.5 pts
Dati di mercato
Aggiornato 18 minuti fa
23 giu 26, 2:1331 dic 26, 23:59
Trend
Solo fondi simulati, nessun denaro realeNon è consulenza finanziaria
Esito scelto
December65%
Trend del volume
$283 lug17g di dati25 lug
Mercati Correlati
Will the NIH indirect cost cap stick?
878,8 €Sì: 11.4%MANIFOLD MARKETS
MANIFOLD MARKETSWill a majority of states legalize psychedelics by 2033?
439,4 €Sì: 11.7%MANIFOLD MARKETS
MANIFOLD MARKETS
If RFK Jr is confirmed HHS Secretary, Marin kindergarten vaccination rate in 2026-2027
431,9 €Below 94%: 22.8%MANIFOLD MARKETS
MANIFOLD MARKETS
Who will Trump nominate as FDA commissioner?
56,9 €Jeffrey Vacirca: 60%
KALSHI
KALSHI
California Clinic Funding Proposition
43,9 €Sì: 34%POLYMARKET
POLYMARKET
Who will Trump announce as next FDA commissioner?
39,4 €No announcement by December 31: 41%POLYMARKET
POLYMARKETAttivi in questi argomenti
Notizie Correlate
Polymarket: Vance leads 2028 at 19.85% as pricing trend softensBlockchain.News
White House pushes Senate Democrats to take 'historic' crypto Clarity Act ethics dealCoindesk
Senate nears bipartisan CLARITY Act deal after ethics breakthroughCrypto News
White House agrees to ethics provisions in market structure billCointelegraph
Polymarket odds show Vance at 19.85% as Epstein files critique hits tapeBlockchain.News
Dick Durbin accuses Todd Blanche of shielding Trump’s crypto empireCrypto NewsRegole
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.